Advertisement

A Modern View of Pharmacokinetics

  • John G. Wagner

Abstract

Publication of the mathematics of accumulation in the one compartment open model by Widmark and Tandberg (1924) and the two papers on the two-compartment open model by the organizer of this conference, Professor Torsten Teorell (1937), were the origins of pharmacokinetics. Many of us who have studied the literature of pharmacokinetics have been amazed at the insight and foresight embodied in Professor Teorell’s two papers. The classical one- and two-compartment open linear models have withstood the test of time, achieved accurate assessment of rates of absorption, metabolism, and excretion when applied to certain specific drugs, and been very useful for predictive purposes. Undoubtedly in the future these classical models will continue to be as useful as they have in the past. These classical pharmacokinetics models are based upon systems of linear differential equations, which may conveniently be integrated using Laplace transforms. Kinetic linearity was defined by Krüger-Thiemer (1968a) as direct proportionality of transfer rates to concentrations or concentration differences.

Keywords

Salicylic Acid Methylene Blue Tissue Binding Nonlinear Pharmacokinetic Compartment Open Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberts, D. S., Bachur, M. R., and Holtzman, J. L., 1971, Clin. Pharmacol. Therap. 12: 96.Google Scholar
  2. Amsel, L. P., and Levy, G., 1969, J. Pharm. Sci. 58: 321.PubMedCrossRefGoogle Scholar
  3. Anderson, E., Norberg, B., and Teger-Nilsson, A. C., 1963, Scand. J. Clin. Lab. Invest. 15: 577.CrossRefGoogle Scholar
  4. Arnold, K., and Gerber, N., 1970, Clin. Pharmacol. Therap. 11: 121.Google Scholar
  5. Atkins, G. L., 1971a, Biochim. Biophys. Acta 248: 405.CrossRefGoogle Scholar
  6. Atkins, G. L., 1971b, Biochim. Biophys. Acta 248: 421.CrossRefGoogle Scholar
  7. Axelson, J. E., and Gibaldi, M., 1972, J. Pharm. Sci. 61: 404.PubMedCrossRefGoogle Scholar
  8. Balasubramaniam, K., Mawer, G. E., and Simons, P. J., 1970, Brit. J. Pharmacol. 40: 578.Google Scholar
  9. Barr, W. H., and Riegelman, S., 1968, “Effect of Capacity Limited Metabolism on Plasma Levels of Free Salicylamide in Man.” Presented to A.Ph.A. Academy of Pharmaceutical Sciences, Miami Beach, Florida, May 6, 1968.Google Scholar
  10. Barr, W. H., and Riegelman, S., 1970a, J. Pharm. Sci. 59: 154.PubMedCrossRefGoogle Scholar
  11. Barr, W. H., and Riegelman, S., 1970b, J. Pharm. Sci. 59: 164.PubMedCrossRefGoogle Scholar
  12. Beckett, A. H., and Rowland, M., 1964, Nature 204: 1203.PubMedCrossRefGoogle Scholar
  13. Beckett, A. H., Boyes, R. N., and Tucker, G. T., 1968a, J. Pharm. Pharmacol. 20: 269.PubMedCrossRefGoogle Scholar
  14. Beckett, A. H., Boyes, R. N., and Tucker, G. T., 1968b, J. Pharm. Pharmacol. 20: 277.PubMedCrossRefGoogle Scholar
  15. Benet, L. Z., 1972, J. Pharm. Sci. 61: 536.PubMedCrossRefGoogle Scholar
  16. Benet, L. Z., and Turi, J. S., 1971, J. Pharm. Sci. 60: 1593.PubMedCrossRefGoogle Scholar
  17. Binnion, P. F., Morgan, L. M., Stevenson, H. M., and Fletcher, E., 1969, Brit. Heart J. 31: 636.PubMedCrossRefGoogle Scholar
  18. Bischoff, K. B., and Dedrick, R. L., 1968, J. Pharm. Sci. 57: 1347.CrossRefGoogle Scholar
  19. Bischoff, K. B., Dedrick, R. L., and Zaharko, D. S., 1970, J. Pharm. Sci. 59: 149.PubMedCrossRefGoogle Scholar
  20. Bischoff, K. G., Dedrick, R. L., Zaharko, D. S., and Longstreth, J. A., 1971, J. Pharm. Sci. 60: 1128.PubMedCrossRefGoogle Scholar
  21. Blum, M., McGilvery, L, Becker, C., and Riegelman, S., 1971, Clin. Res. 19: 121, abstract.Google Scholar
  22. Bray, H. G., Thorpe, W. V., and White, K., 1951, Biochem. J. 48: 88.PubMedGoogle Scholar
  23. Buell, J., and Kalaba, R., 1968, Technical Report USCEE-312, Electronic Sciences Laboratory, University of Southern California, Los Angeles, California.Google Scholar
  24. Burns, J. J., and Conney, A. H., 1965, Proc. Roy. Soc. Med. 58: 955.PubMedGoogle Scholar
  25. Carlson, L. A., and Hallberg, D., 1963, Acta Physiol. Scand. 59: 52.PubMedCrossRefGoogle Scholar
  26. Chiou, W. L., and Riegelman, S., 1969, J. Pharm. Sci. 58: 1500.PubMedCrossRefGoogle Scholar
  27. Civen, M., Ulrich, R., Trimmer, B. M., and Brown, C. B., 1967, Science 157: 1563.PubMedCrossRefGoogle Scholar
  28. Coffey, J. J., Bullock, F. J., and Schoenemann, P. T., 1971, J. Pharm. Sci. 60: 1623.PubMedCrossRefGoogle Scholar
  29. Crouthamel, W., Doluisio, J. T., Johnson, R. E., and Diamond, L., 1970, J. Pharm. Sci. 59: 878.PubMedCrossRefGoogle Scholar
  30. Curry, S. H., 1970, J. Pharm. Pharmacol. 22: 753.PubMedCrossRefGoogle Scholar
  31. Dayton, P. G., Cucinell, S. A., Weiss, M., and Perei, J. M., 1967, J. Pharmacol. Exp. Therap. 158: 305.Google Scholar
  32. Dearden, J. C., and Tomilson, E., 1971, J. Pharm. Pharmacol. 23: 685, Suppl.Google Scholar
  33. Dedrick, R. L., and Bischoff, K. B., 1968, Chem. Engr. Prog. Symp. Ser. 64: 32.Google Scholar
  34. Dettli, L., and Spring, P., 1966, Helv. Med. Acta 33: 291.Google Scholar
  35. DiSanto, A. R., and Wagner, J. G., 1969, J. Pharm. Sci. 58: 1077.PubMedCrossRefGoogle Scholar
  36. DiSanto, A. R., 1971, “A New Nonlinear Pharmacokinetic Model with Specific Application to Methylene Blue.” A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Pharmacy) at the University of Michigan.Google Scholar
  37. DiSanto, A. R., and Wagner, J. G., 1972a, J. Pharm. Sci. 61: 598.PubMedCrossRefGoogle Scholar
  38. DiSanto, A. R., and Wagner, J. G., 1972b, J. Pharm. Sci. 61: 552.PubMedCrossRefGoogle Scholar
  39. DiSanto, A. R., and Wagner, J. G., 1972c, J. Pharm. Sci. 61: 1086.PubMedCrossRefGoogle Scholar
  40. DiSanto, A. R., and Wagner, J. G., 1972d, J. Pharm. Sci. 61: 1090.PubMedCrossRefGoogle Scholar
  41. Dixson, R. L., Owens, E. S., and Rall, D. P., 1969, J. Pharm. Sci. 58: 1106.CrossRefGoogle Scholar
  42. Doluisio, J. T., and Dittert, L. W., 1969, Clin. Pharmacol. Therap. 10: 690.Google Scholar
  43. Drach, J. C., Howell, J. P., Borondy, P. E., and Glazko, A. J., 1970, Proc. Soc. Exp. Biol. Med. 135: 849.PubMedGoogle Scholar
  44. Drucker, M. M., Blondheim, S. H., and Wislicki, L., 1964, Clin. Sci. 27: 133.PubMedGoogle Scholar
  45. Eggleton, M. G., 1940, J. Physiol. (London) 98: 239.Google Scholar
  46. Estes, J. W., Pelikan, E. W., and Krüger-Thiemer, E., 1969, Clin. Pharmacol. Therap. 10: 329.Google Scholar
  47. Fuwa, T., Iga, T., Hanano, M., Nogami, H., and Kashima, K., 1971, J. Pharm. Soc. Japan 91: 1223.Google Scholar
  48. Gerber, N., and Arnold, K., 1969, J. Pharmacol. Exp. Therap. 167: 77Google Scholar
  49. Gerber, N., and Wagner, J. G., 1972, Res. Comm. Chem. Pathol. Pharmacol. 3: 455.Google Scholar
  50. Gerber, N., Welles, W. L., Lynn, R., Rangno, R. E., Sweetman, B. J., and Bush, M. T., 1971, J. Pharmacol. Exp. Therap. 178: 567.Google Scholar
  51. Gibaldi, M., and Levy, G., 1972, J. Pharm. Sci. 61: 567.PubMedCrossRefGoogle Scholar
  52. Gillette, J. R., 1971, Ann. N. Y. Acad. Sci. 179: 43.PubMedCrossRefGoogle Scholar
  53. Glazko, A. J., Chang, T., Bankema, J., Dill, W. A., Gaulet, J. R., and Buckanan, R. A., 1969, Clin. Pharmacol. Therap. 10: 498.Google Scholar
  54. Goresky, C. A., 1964, Am. J. Physiol. 207: 13.PubMedGoogle Scholar
  55. Hallberg, D., 1965a, Acta Physiol. Scand. 64: 299.PubMedCrossRefGoogle Scholar
  56. Hallberg, D., 1965b, Acta Physiol. Scand. 64: 306.PubMedCrossRefGoogle Scholar
  57. Henderson, E. S., Adamson, R. H., Denham, C., and Oliverio, V. T., 1965, Cancer Res. 25: 1008.PubMedGoogle Scholar
  58. Hepner, G. W., Booth, C. C., Cowan, J., Hoffbrand, A. V., and Mollin, D. L., 1968, Lancet Aug. 10: 302.CrossRefGoogle Scholar
  59. Hill, J. B., 1970, Federation Proc. 29: 934, abstract.Google Scholar
  60. Hogben, C. A. M., Tocco, D. J., Brodie, B. B., and Schanker, L. S., 1959, J. Pharmacol. Exp. Therap. 125: 275.Google Scholar
  61. Huang, K. C., and Lin, D. S. T., 1965, Am. J. Physiol. 208: 391.PubMedGoogle Scholar
  62. Jacquez, J. A., Bellman, R., and Kalaba, R., 1960, Bull. Math. Biophys. 22: 309.CrossRefGoogle Scholar
  63. Jusko, W. J., and Levy, G., 1970, J. Pharm. Sci. 59: 722.CrossRefGoogle Scholar
  64. Jusko, W. J., Levy, G., Yaffe, S. Y., and Gorodescher, R., 1970, J. Pharm. Sci. 59: 473.PubMedCrossRefGoogle Scholar
  65. Kakemi, K., Arita, T., Sezaki, H., and Hanano, M., 1963, J. Pharm. Soc. Japan 83: 260.Google Scholar
  66. Kakemi, K., Arita, T., Hori, R., Koniski, R., and Nishimura, K., 1969, Chem. Pharm. Bull. (Tokyo) 17: 248.CrossRefGoogle Scholar
  67. Kondritzer, A. A., Zvirblis, P., Goodman, A., and Paplanas, S. H., 1968, J. Pharm. Sci. 57: 1142.PubMedCrossRefGoogle Scholar
  68. Krüger-Thiemer, E., Diller, W., and Bünger, P., 1966, Antimicrobiol Agents Chemother. 1965: 183.Google Scholar
  69. Krüger-Thiemer, E., 1968a, Farmaco (Pavia) Ed. Sci. 23: 717.Google Scholar
  70. Krüger-Thiemer, E., 1968b, “Pharmacokinetics and Dose-Concentration Relationships,” in: Proceedings of the Third International Pharmacological Meeting, July 24–30, 1966, Vol. 7., Physico-Chemical Aspects of Drug Actions, Pergamon Press, New York. Vol. 7, p. 63.Google Scholar
  71. Krüger-Thiemer, E., and Levine, R., 1968c, Arzneim. Forsch. 18: 1575.Google Scholar
  72. Lanman, C., Muranishi, S., and Schanker, L. S., 1970, Pharmacologist 12: 293, abstract.Google Scholar
  73. Lauger, P., and Stark, G., 1970, Biochem. Biophys. Acta 211: 458.PubMedCrossRefGoogle Scholar
  74. Lauterback, F., 1968, Biochem. Biophys. Acta 150: 146.CrossRefGoogle Scholar
  75. Levy, G., 1965a, J. Pharm. Sci. 54: 496.PubMedCrossRefGoogle Scholar
  76. Levy, G., 1965b, J. Pharm. Sci. 54: 959.PubMedCrossRefGoogle Scholar
  77. Levy, G., 1968, “Dose-Dependent Effects in Pharmacokinetics,” in: Importance of Fundamental Principles in Drug Evaluation (Tedeschi, D. H. and Tedeschi, R. E., eds.), Raven Press, New York.Google Scholar
  78. Levy, G., 1971, Chem. Biol. Interactions 3: 291.CrossRefGoogle Scholar
  79. Levy, G., and Amsel, L. P., 1966, Biochem. Pharmacol. 15: 1033.PubMedCrossRefGoogle Scholar
  80. Levy, G., Amsel, L. P., and Elliott, H. C., 1969b, J. Pharm. Sci. 58: 827.PubMedCrossRefGoogle Scholar
  81. Levy, G., and Gibaldi, M., 1972, Ann. Rev. Pharmacol. 12: 85.PubMedCrossRefGoogle Scholar
  82. Levy, G., and Jusko, W. J., 1966, J. Pharm. Sci. 55: 285.PubMedCrossRefGoogle Scholar
  83. Levy, G., and Matsuzawa, T., 1966, J. Pharm. Sci. 55: 222.PubMedCrossRefGoogle Scholar
  84. Levy, G., and Matsuzawa, T., 1967, J. Pharmacol. Exp. Therap. 156: 285.Google Scholar
  85. Levy, G., and Nagashima, R., 1969, J. Pharm. Sci. 58: 1001.PubMedCrossRefGoogle Scholar
  86. Levy, G., and Procknal, J. A., 1968, J. Pharm. Sci. 57: 1330.PubMedCrossRefGoogle Scholar
  87. Levy, G., and Regardh, C. G., 1971, J. Pharm. Sci. 60: 608.PubMedCrossRefGoogle Scholar
  88. Levy, G., Tsuchuja, T., and Amsel, L. P., 1972, Clin. Pharmacol. Therap. 13: 258.Google Scholar
  89. Levy, G., Vogel, A. W., and Amsel, L. P., 1969c, J. Pharm. Sci. 58: 503.PubMedCrossRefGoogle Scholar
  90. Levy, G., Weintraub, L., Matsuzawa, T., and Oles, S. R., 1966, J. Pharm. Sci. 55: 1319.PubMedCrossRefGoogle Scholar
  91. Levy, G., and Yamada, H., 1970, J. Pharm. Pharmacol. 22: 964.PubMedCrossRefGoogle Scholar
  92. Levy, G., and Yamada, H., 1971, J. Pharm. Sci. 60: 215.PubMedCrossRefGoogle Scholar
  93. Levy, G., and Yaffe, S. J., 1968, Clin. Toxicol. 1: 409.CrossRefGoogle Scholar
  94. Lundquist, F. and Wolthers, H., 1958, Acta Pharmacol. Toxicol. 14: 265.CrossRefGoogle Scholar
  95. Mackey, M. C., 1971a, Biophys. J. 11: 75.PubMedCrossRefGoogle Scholar
  96. Mackey, M. C., 1971b, Biophys. J. 11: 91.PubMedCrossRefGoogle Scholar
  97. Marks, B. H., Dutta, S., Gauthier, J., and Elliott, D., 1964, J. Pharmacol. Therap. 145: 351.Google Scholar
  98. Martin, B. K., 1965, Nature 207: 274.PubMedCrossRefGoogle Scholar
  99. Mather, L. E., Long, G. J., and Thomas, J. T., 1971, Clin. Pharmacol. Therap. 12: 935.Google Scholar
  100. McMartin, C., and Simpson, P., 1971, Clin. Pharmacol. Therap. 12: 73.Google Scholar
  101. Meyer, M. C., and Guttman, D. E., 1968, J. Pharm. Sci. 57: 895.PubMedCrossRefGoogle Scholar
  102. Michaelis, L., and Menten, M. L., 1913, Biochem. Z. 49: 333.Google Scholar
  103. Mudge, G. H., and Weiner, I. M., 1963, “Renal Excretion of Weak Organic Acids and Bases,” in: Drugs and Membranes, Vol. IV (Hogben, C. A. M., ed.), The Macmillan Company, New York, p. 157.Google Scholar
  104. Nagashima, R., and Levy, G., 1969, J. Pharm. Sci. 58: 845.PubMedCrossRefGoogle Scholar
  105. Nagashima, R., and Levy, G., 1968, J. Pharm. Sci. 57: 1991.PubMedCrossRefGoogle Scholar
  106. Nagashima, R., Levy, G., and Back, N., 1968a, J. Pharm. Sci. 57: 68.PubMedCrossRefGoogle Scholar
  107. Nagashima, R., Levy, G., and Nelson, E., 1968b, J. Pharm. Sci. 57: 58.PubMedCrossRefGoogle Scholar
  108. Nagashima, R., Levy, G., and O’Reilly, R. A., 1968c, J. Pharm. Sci. 57: 1888.PubMedCrossRefGoogle Scholar
  109. Nagashima, R., Levy, G., and Sarcione, E. J., 1968d, J. Pharm. Sci. 57: 1881.PubMedCrossRefGoogle Scholar
  110. Nagwekar, J. B., and Unnikrishnan, A., 1971, J. Pharm. Sci. 60: 375.PubMedCrossRefGoogle Scholar
  111. Neal, J. L., 1972, J. Theoret. Biol. 35: 113.CrossRefGoogle Scholar
  112. Nelson, E., Hanano, M., and Levy, G., 1966, J. Pharmacol. Exp. Therap. 153: 159.Google Scholar
  113. Nordquist, P., Harthorn, J. G., and Karlson, R., 1965, Nord. Med. 74: 1024.Google Scholar
  114. Ochsenfahrt, H., and Winne, D., 1968, Life Sci. 7: 493.PubMedCrossRefGoogle Scholar
  115. Oldendorf, W. H., 1968, Intern. J. Appl. Radiation Isotopes 19: 411.CrossRefGoogle Scholar
  116. O’Reilly, W. J., Pitt, P. A., and Ryan, A. J., 1971, Brit. J. Pharmacol. 43: 167.Google Scholar
  117. Patlak, C. S., 1961, Bull, Math. Biophys. 23: 173.CrossRefGoogle Scholar
  118. Paumgartner, G., Probst, P., Kraines, R., and Leevy, C. M., 1970, Ann. N. Y. Acad. Sci. 170: 134.CrossRefGoogle Scholar
  119. Pfeffer, M., Schor, J. M., Bolton, S., and Jacobson, R., 1968, J. Pharm. Sci. 57: 1375.PubMedCrossRefGoogle Scholar
  120. Radzialowski, F. M., and Bousquet, W. F., 1967, Life Sci. 6: 2545.PubMedCrossRefGoogle Scholar
  121. Rees, E. D., Mandelstram, P., Lowry, J. A., and Lipscomb, H., 1971, Biochem. Biophys. Acta 225: 96.PubMedCrossRefGoogle Scholar
  122. Reeve, E. R., 1964, “The Plasma Albumin System. A First Attempt at a Kinetic Description in Dynamic Clinical Studies with Radioisotopes.” Proceedings of a Symposium held at the Oak Ridge Institute of Nuclear Studies, October 21–25, 1963. U.S. Department of Commerce, TID 7678, Office of Technical Services, U.S. Dept. of Commerce, Washington, D.C., p. 445.Google Scholar
  123. Rowland, M., Benet, L. Z., and Riegelman, S., 1970, J. Pharm. Sci. 59: 364.PubMedCrossRefGoogle Scholar
  124. Rowland, M., and Riegelman, S., 1968, J. Pharm. Sci. 57: 1313.CrossRefGoogle Scholar
  125. Rowland, M., Riegelman, S., and Epstein, W. L., 1968, J. Pharm. Sci. 57: 984.PubMedCrossRefGoogle Scholar
  126. Schachter, D., and Manis, J. G., 1958. J. Clin. Invest. 37: 800.PubMedCrossRefGoogle Scholar
  127. Schanker, L. S., 1962, Biochem. Pharmacol. 11: 253.PubMedCrossRefGoogle Scholar
  128. Schanker, L. S., and Morrison, A. S., 1965, Intern J. Nevropharmacol. 4: 27.CrossRefGoogle Scholar
  129. Schoenfield, L. J., McGill, D. B., and Foulk, W. T., 1964, J. Clin. Invest. 43: 1424.PubMedCrossRefGoogle Scholar
  130. Sedman, A. J., and Wagner, J. G., 1972, “Quantitative Pooling of Both Parallel Michaelis-Menten Formation Equations and Langmuir-type Equations for Binding of Drugs to Tissues.” Abstracts of Symposia and Contributed Papers Presented to the A.Ph.A. Academy of Pharmaceutical Sciences at the 119th Annual Meeting of the American Pharmaceutical Association, Houston, Texas, April 22–28, 1972, Vol. 2, No. 1, p. 61, abstract 16.Google Scholar
  131. Shibasaki, J., Koizumi, T., and Higuchi, W., 1968a, Chem. Pharm. Bull. (Tokyo) 16: 2273.CrossRefGoogle Scholar
  132. Shibasaki, J., Koizumi, T., and Tanaka, T., 1968b, Chem. Pharm. Bull. (Tokyo) 16: 1661.CrossRefGoogle Scholar
  133. Shibasaki, J., Konishi, R., Takeda, Y., and Koizumi, T., 1971, Chem. Pharm. Bull. (Tokyo) 19: 1800.CrossRefGoogle Scholar
  134. Sholkoff, S. D., Eyering, E. J., Rowland, M., and Riegelman, S., 1967, Arthritis Rheumatism 10: 348.PubMedCrossRefGoogle Scholar
  135. Shore, P. A., Brodie, B. B., and Hogben, C. A. M., 1957, J. Pharmacol. Exp. Therap. 119: 361.Google Scholar
  136. Sidell, F. R., Groff, W. A., and Ellin, R. I., 1969, J. Pharm. Sci. 58: 1093.PubMedCrossRefGoogle Scholar
  137. Smith, R. B., Dittert, L. W., Griffin, W. D., Jr., and Doluisio, J. T., 1973, J. Pharmacokinetics and Biopharmaceutics 1: 5.CrossRefGoogle Scholar
  138. Somani, S. M., Schumacher, D., Thompson, R., and McDonald, R. H., Jr., 1971, Fed. Proc. 30: 1335, abstract.Google Scholar
  139. Spears, G., Sneyd, J. G. T., and Loten, E. G., 1971, Biochem. J. 125: 1149.PubMedGoogle Scholar
  140. Strum, W. B., Nixon, P. F., Binden, H. J., and Bertino, J. R., 1970, Clin. Res. 18: 389, abstract.Google Scholar
  141. Stupp, H., Rouch, S., Sous, H., Brun, J. P., and Lagler, F., 1967, Arch. Otolaryngol. 86: 63.Google Scholar
  142. Suzuki, A., Higuchi, W. I., and Ho, N. F. H., 1970a, J. Pharm. Sci. 59: 644.PubMedCrossRefGoogle Scholar
  143. Suzuki, A., Higuchi, W. I., and Ho, N. F. H., 1970a, J. Pharm. Sci. 59: 651.PubMedCrossRefGoogle Scholar
  144. Suzuki, T., Saitoh, Y., and Nishihara, K., 1970b, Chem. Pharm. Bull. (Tokyo) 18: 405.CrossRefGoogle Scholar
  145. Teorell, T., 1937, Arch. Inter. Pharmacodyn. 57: 205 and 226.Google Scholar
  146. Thorp, J. M., 1964, “The Influence of Plasma Proteins on the Action of Drugs,” in: Absorption and Distribution of Drugs, p. 64 (Binns, T. B., ed.), The Williams and Wilkins Company, Baltimore.Google Scholar
  147. Timmes, J. J., Demos, N. J., and Chong, S. I., 1971. Clin. Pharmacol. Therap. 12: 920.Google Scholar
  148. Tomura, M., and Akera, T., 1971, Jap. J. Pharmacol. 21: 682.PubMedCrossRefGoogle Scholar
  149. Tsuchuja, T., and Levy, G., 1972, J. Pharm. Sci. 61: 541.CrossRefGoogle Scholar
  150. Wagner, J. G., 1966, Can. J. Pharm. Sci. 1: 55.Google Scholar
  151. Wagner, J. G., 1967, J. Pharm. Sci. 56: 586.PubMedCrossRefGoogle Scholar
  152. Wagner, J. G., 1968a, Ann. Rev. Pharmacol. 8: 67.PubMedCrossRefGoogle Scholar
  153. Wagner, J. G., 1968b, J. Theoret. Biol. 20: 173.CrossRefGoogle Scholar
  154. Wagner, J. G., 1971a, Biopharmaceutics and Relevant Pharmacokinetics, Chapter 40; p. 302, Drug Intelligence Publications, Hamilton, Illinois.Google Scholar
  155. Wagner, J. G., 1971b, J. Mondial de Pharmacie 14: 279.Google Scholar
  156. Wagner, J. G., 1973, “Properties of the Michaelis-Menten Equation and Its Integrated Form Which Are Useful in Pharmacokinetics,” J. Pharmacokinetics & Biopharmaceutics, 1: 103.CrossRefGoogle Scholar
  157. Wagner, J. G. and Damiano, R. E., 1968, J. Clin. Pharmacol. J. New Drugs 8: 102.PubMedGoogle Scholar
  158. Wagner, J. G., and Patel, J. A., 1972, “Variations in Absorption and Elimination Rates of Ethyl Alcohol in a Single Subject,” Res. Com. Chem. Pathol. Pharmacol. 4: 61.Google Scholar
  159. Wagner, J. G., and Sedman, A. J., 1973, “Quantitation of Rate of Gastrointestinal and Buccal Absorption of Acidic and Basic Drugs Based on Extraction Theory,” J. Pharmacokinetics & Biopharmaceutics, 1: 23.CrossRefGoogle Scholar
  160. Weiner, I. M., and Mudge, G. H., 1964, Am. J. Med. Sci. 36: 743.CrossRefGoogle Scholar
  161. Weiner, I. M., Blanchard, L. C., and Mudge, G. H., 1964a, Am. J. Physiol. 207: 953.PubMedGoogle Scholar
  162. Weiner, I. M., Glasser, J. E., and Lach, L., 1964b, Am. J. Physiol. 207: 964.PubMedGoogle Scholar
  163. Widmark, E. M. P., 1933, Biochem. Z. 267: 128.Google Scholar
  164. Widmark, E. M. P., 1933, Biochem. Z. 267: 135.Google Scholar
  165. Widmark, E., and Tandberg, J., 1924, Biochem. Z. 147: 358.Google Scholar
  166. Wiegand, R. G., and Chun, A. H. C., 1972, J. Pharm. Sci. 61: 425.PubMedCrossRefGoogle Scholar
  167. Wilbrandt, W., and Rosenberg, P., 1961, Pharmacol. Rev. 13: 109.PubMedGoogle Scholar
  168. Williams, R. T., Milburn, P., and Smith, R. L., 1965, Ann. N. Y. Acad. Sci. 123: 110.PubMedCrossRefGoogle Scholar
  169. Winkler, K. and Tygstrup, H., 1964, J. Clin. Lab. Invest. 16: 481.CrossRefGoogle Scholar
  170. Winne, D., 1970, J. Theroret. Biol. 27: 1.CrossRefGoogle Scholar
  171. Yesair, D. W., Callahan, M., Remington, L., and Hensler, C. J., 1970, Biochem. Pharmacol. 19: 1579.PubMedCrossRefGoogle Scholar
  172. Zaharko, D. S., Dedrick, R. L., and Oliverio, V. T., 1970, Fed. Proc. 29: 932, abstract.Google Scholar

Copyright information

© Springer Science+Business Media New York 1972

Authors and Affiliations

  • John G. Wagner
    • 1
  1. 1.College of Pharmacy and Upjohn Center for Clinical PharmacologyThe University of MichiganAnn ArborUSA

Personalised recommendations